REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/20/2025
Back to search
Official data from USPTO
SPIROVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/22/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
11/22/2019
Registration date
10/20/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
16
Owner location
PHILADELPHIA, PA
Examiner
KETCHUM,BRENDAN J
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of a design a pair of lungs followed by the word "SPIROVANT".
Holders and representatives
Holders
SPIROVANT SCIENCES LLC
SUMITOVANT BIOPHARMA, INC.
Roivant Sciences GmbH
Representatives
Karen L. Elbing Clark+Elbing LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of cystic fibrosispulmonary diseasesdisorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of cystic fibrosispulmonary diseasesdisorders and conditions
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceuticalbiomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
26 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/13/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/20/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/26/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/25/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/03/2020
GNRT
NON-FINAL ACTION E-MAILED
01/03/2020
CNRT
NON-FINAL ACTION WRITTEN
01/03/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/20/2019
ALIE
ASSIGNED TO LIE
12/19/2019
DOCK
ASSIGNED TO EXAMINER
12/18/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/06/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2019
NWAP
NEW APPLICATION ENTERED
11/26/2019
Continuous trademark protection
Get notified about every new filing that threatens SPIROVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.